18th Dec 2020 08:24
Ap19
FORM 8.3 - Amendment to Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 15 December 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
3,063,010 | 2.38% | 688,681 | 0.53% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
597,705 | 0.46% | 739,005 | 0.57% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
3,660,715 | 2.84% | 1,427,686 | 1.11% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 209.0700 USD |
Purchase | 1 | 210.9900 USD |
Purchase | 2 | 209.4100 USD |
Purchase | 2 | 208.9550 USD |
Purchase | 3 | 210.6883 USD |
Purchase | 6 | 209.4633 USD |
Purchase | 6 | 207.9700 USD |
Purchase | 8 | 209.7787 USD |
Purchase | 11 | 209.6518 USD |
Purchase | 17 | 210.3670 USD |
Purchase | 22 | 208.5900 USD |
Purchase | 26 | 208.7991 USD |
Purchase | 34 | 209.5905 USD |
Purchase | 35 | 209.7302 USD |
Purchase | 47 | 209.0212 USD |
Purchase | 50 | 208.4804 USD |
Purchase | 51 | 210.0464 USD |
Purchase | 61 | 210.0398 USD |
Purchase | 62 | 208.4996 USD |
Purchase | 62 | 209.0048 USD |
Purchase | 100 | 207.8500 USD |
Purchase | 100 | 205.9800 USD |
Purchase | 100 | 205.9750 USD |
Purchase | 130 | 207.9557 USD |
Purchase | 160 | 206.1612 USD |
Purchase | 390 | 210.0112 USD |
Purchase | 391 | 206.2492 USD |
Purchase | 564 | 205.5971 USD |
Purchase | 583 | 206.5156 USD |
Purchase | 646 | 206.0739 USD |
Purchase | 905 | 206.0579 USD |
Purchase | 1,028 | 206.0686 USD |
Purchase | 1,599 | 210.2986 USD |
Purchase | 2,278 | 209.1042 USD |
Purchase | 2,410 | 206.7553 USD |
Purchase | 2,610 | 210.0100 USD |
Purchase | 3,521 | 207.0939 USD |
Purchase | 3,702 | 209.7766 USD |
Purchase | 6,489 | 210.0022 USD |
Purchase | 7,717 | 209.4994 USD |
Purchase | 12,591 | 209.7934 USD |
Purchase | 12,905 | 209.9904 USD |
Sale | 1 | 210.6400 USD |
Sale | 1 | 210.6300 USD |
Sale | 1 | 210.5500 USD |
Sale | 5 | 210.0060 USD |
Sale | 11 | 209.6518 USD |
Sale | 91 | 206.5100 USD |
Sale | 100 | 205.5800 USD |
Sale | 132 | 210.5012 USD |
Sale | 200 | 205.5857 USD |
Sale | 264 | 205.6121 USD |
Sale | 302 | 209.6935 USD |
Sale | 400 | 210.0001 USD |
Sale | 603 | 210.3212 USD |
Sale | 719 | 209.7810 USD |
Sale | 766 | 208.4364 USD |
Sale | 1,004 | 210.2810 USD |
Sale | 2,721 | 210.0100 USD |
Sale | 6,947 | 209.9503 USD |
Sale | 7,717 | 209.4994 USD |
Sale | 11,318 | 206.8584 USD |
Sale | 12,905 | 209.9904 USD |
Sale | 14,585 | 209.8751 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
| Full details of any agreement, arrangement or understanding between the person disclosing |
| and any other person relating to the voting rights of any relevant securities under any option |
| referred to on this form or relating to the voting rights or future acquisition or disposal of any |
| relevant securities to which any derivative referred to on this form is referenced. If none, this |
| should be stated. |
| NONE |
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 18 Dec 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20201218005180/en/
Copyright Business Wire 2020
Related Shares:
Barclays